Service for the analysis of gene expression data using quantum resonance interferometry targets laboratories doing large-scale microarray research and development
ViaLogy, inventor and developer of active signal processing software, has announced the launch of ViaLogy Microarray Service, the first product based on its quantum resonance interferometry (QRI) technology.
ViaLogy Microarray Service is a highly focused application service provider for gene expression data.
Targeted for large-scale users of microarrays such as major pharmaceutical, biotech and agricultural companies and institutional core laboratories, ViaLogy Microarray Service reprocesses microarray data files from existing microarray instrumentation and databases to provide sensitivity, specificity and reproducibility unattainable by any other commercially available technology.
It will be available online on a pay-per-use basis.
QRI technology can amplify signals by 100 to 10,000 times more than conventional methods, allowing researchers to detect and quantify hybridisation events on microarrays that previously went undetected due to background noise.
At the same time, QRI gives biological researchers and drug developers increased confidence in results from their complex gene expression studies by eliminating most false negatives, providing better statistics on false positives, and significantly improving reproducibility.
Complex biology that is coded and controlled by DNA and RNA can now be studied at a more advanced level of sensitivity and specificity.
The ViaLogy Microarray Service is pre-calibrated and user-selectable for several different types of Affymetrix GeneChip brand microarrays.
ViaLogy is working with users and microarray vendors to add new formats such as glass-slides, optimise work-flows and select appropriate distribution channels.
Users will securely logon via the internet or point-to-point network to the service, which uses HP Integrity servers running Intel's latest 64 bit Itanium 2 processors, at an IBM co-hosted computing facility.
Files are transferred in standard formats and the results are ready for download within 24 hours.
"We are pleased to be working with IBM and HP to provide a very robust, on-line implementation for our first data analysis service," said Douglas Lane, ViaLogy's president and CEO.
"Gene expression and genotyping have become mission critical applications in many research and development laboratories and microarray use is growing in clinical diagnostics".
The ViaLogy Microarray Service, already available to ViaLogy's clients for glass slides and Affymetrix's GeneChip microarrays by sending files on CD-ROM, will be available on-line beginning mid-December 2003.
